Kevin M. Lalande is Founding Managing Director and Chief Investment Officer of Santé, an investment partnership with $1 billion in capital under management in two different strategies.

The first strategy, Santé Ventures, was founded in 2006 to create and finance innovative new healthcare and life science companies, including LDR Medical (Zimmer Biomet), Explorys (IBM Corp), AbVitro (Bristol Myers Squibb), Molecular Templates (Nasdaq: MTEM), Millipede Medical (Boston Scientific), TVA Medical (Becton Dickenson), Claret Medical (Boston Scientific), Lumos Pharms (Nasdaq: LUMO), and Farapulse (Boston Scientific).

The second strategy, Santé Capital, is a systematic hedge fund that began trading capital in 2015 based on quantitative and natural language machine learning algorithms. Kevin conceived the investment strategy, developed the original MindRank algorithms, and assembled a seasoned team of data scientists and software engineers to help drive this business.

Before his current roles, Kevin was a venture capitalist with Austin Ventures for seven years and was a management consultant with McKinsey & Company. Kevin received a bachelor’s degree with honors in Electrical & Computer Engineering, an MBA with the highest distinction from Harvard Business School, where he was both a Baker Scholar and a Siebel Scholar, and a graduate certificate in Artificial Intelligence from Stanford University.